Kymera Therapeutics Inc —— 资产负债表 (NASDAQ:KYMR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 487.18 M605.9 M603.13 M575.76 M978.03 M1.74 B 负债总额 203.29 M146.27 M112.98 M180.79 M142.42 M163.15 M 权益总额 283.89 M459.64 M490.15 M394.97 M835.62 M1.58 B 负债及股东权益总额 487.18 M605.9 M603.13 M575.76 M978.03 M1.74 B 总债务 —————— 净债务 ——————

新闻

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Kymera在Leerink全球医疗保健会议上的战略见解:药物开发进展

Kymera at Leerink Global Healthcare: Strategic Insights on Drug Development

Kymera将在AAD会议上公布特应性皮炎试验数据

Kymera to present atopic dermatitis trial data at AAD meeting

Kymera at TD Cowen Conference: Strategic Insights on Drug Programs

Stephens raises Kymera Therapeutics price target to $100 on pipeline

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway

摩根士丹利下调Kymera Therapeutics目标价,关注管线进展

Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress